Ultragenyx Pharmaceutical Inc. 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-26 4:44 pm Sale | 2021-10-21 | 13D | Arcturus Therapeutics Holdings Inc. ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,200,000 4.600% | -200,000 (-14.29%) | Filing |
| 2021-08-12 5:09 pm Sale | 2021-08-10 | 13D | Arcturus Therapeutics Holdings Inc. ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,400,000 5.300% | -800,000 (-36.36%) | Filing |
| 2020-12-10 4:51 pm Sale | 2020-12-08 | 13D | Arcturus Therapeutics Holdings Inc. ARCT | Ultragenyx Pharmaceutical Inc. RARE | 2,200,000 9.000% | -800,000 (-26.67%) | Filing |